APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meloxicam Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Meloxicam Drugs Industry Growth and Trends Forecast to 2032

20 December 2025101 pages

Choose your research edition.

Industry ResearchMeloxicam Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Meloxicam Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Meloxicam Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meloxicam Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Meloxicam Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Meloxicam Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Meloxicam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Meloxicam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meloxicam Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Meloxicam Drugs include Boehringer Ingelheim, Iroko Pharmaceuticals, Lupin, Nipro, Novitium Pharma, Zydus, Jiangsu Jibeier Pharmaceutical, Kelun Pharmaceutical and Luye Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Meloxicam Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Meloxicam Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Meloxicam Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Meloxicam Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Meloxicam Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Meloxicam Drugs Market by Company

Boehringer Ingelheim

Iroko Pharmaceuticals

Lupin

Nipro

Novitium Pharma

Zydus

Jiangsu Jibeier Pharmaceutical

Kelun Pharmaceutical

Luye Pharma

Qilu Pharmaceutical

Simcere Pharmaceutical

Yangtze River Pharmaceutical

YaoPharma

Zhejiang Xianju Pharmaceutical

Meloxicam Drugs Segment by Type

Oral Preparations

Topical Preparations

Injections

Meloxicam Drugs Segment by Application

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Meloxicam Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meloxicam Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meloxicam Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meloxicam Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meloxicam Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Meloxicam Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Preparations Table 2. Major Company of Topical Preparations Table 3. Major Company of Injections Table 4. Global Meloxicam Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Meloxicam Drugs Sales by Type (2021-2026) & (W Units) Table 6. Global Meloxicam Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Meloxicam Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Meloxicam Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Meloxicam Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Meloxicam Drugs Sales by Type (2027-2032) & (W Units) Table 11. Global Meloxicam Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Meloxicam Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Meloxicam Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Meloxicam Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Meloxicam Drugs Sales by Type (2021-2026) & (W Units) Table 16. North America Meloxicam Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Meloxicam Drugs Sales by Type (2021-2026) & (W Units) Table 18. Europe Meloxicam Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Meloxicam Drugs Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Meloxicam Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Meloxicam Drugs Sales by Type (2021-2026) & (W Units) Table 22. Latin America Meloxicam Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Meloxicam Drugs Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Meloxicam Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Meloxicam Drugs Industry Trends Table 26. Meloxicam Drugs Industry Drivers Table 27. Meloxicam Drugs Industry Opportunities and Challenges Table 28. Meloxicam Drugs Industry Restraints Table 29. Global Meloxicam Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Meloxicam Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Meloxicam Drugs Sales by Company (2021-2026) & (W Units) Table 32. Global Meloxicam Drugs Sales Share by Company (2021-2026) Table 33. Global Meloxicam Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Meloxicam Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Meloxicam Drugs Major Company Production Sites and Headquarters Table 36. Global Meloxicam Drugs Company, Product Type & Application Table 37. Global Meloxicam Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Meloxicam Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Meloxicam Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Meloxicam Drugs Sales by Region (2021-2026) & (W Units) Table 42. Global Meloxicam Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Meloxicam Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Meloxicam Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Meloxicam Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Meloxicam Drugs Sales by Region (2027-2032) & (W Units) Table 47. Global Meloxicam Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Meloxicam Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Meloxicam Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Meloxicam Drugs Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Meloxicam Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Meloxicam Drugs Sales by Application (2021-2026) & (W Units) Table 53. Global Meloxicam Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Meloxicam Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Meloxicam Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Meloxicam Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Meloxicam Drugs Sales by Application (2027-2032) & (W Units) Table 58. Global Meloxicam Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Meloxicam Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Meloxicam Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Meloxicam Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Meloxicam Drugs Sales by Application (2021-2026) & (W Units) Table 63. North America Meloxicam Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Meloxicam Drugs Sales by Application (2021-2026) & (W Units) Table 65. Europe Meloxicam Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Meloxicam Drugs Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Meloxicam Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Meloxicam Drugs Sales by Application (2021-2026) & (W Units) Table 69. Latin America Meloxicam Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Meloxicam Drugs Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Meloxicam Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Boehringer Ingelheim Company Information Table 73. Boehringer Ingelheim Business Overview Table 74. Boehringer Ingelheim Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Boehringer Ingelheim Meloxicam Drugs Product Portfolio Table 76. Boehringer Ingelheim Recent Development Table 77. Iroko Pharmaceuticals Company Information Table 78. Iroko Pharmaceuticals Business Overview Table 79. Iroko Pharmaceuticals Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Iroko Pharmaceuticals Meloxicam Drugs Product Portfolio Table 81. Iroko Pharmaceuticals Recent Development Table 82. Lupin Company Information Table 83. Lupin Business Overview Table 84. Lupin Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Lupin Meloxicam Drugs Product Portfolio Table 86. Lupin Recent Development Table 87. Nipro Company Information Table 88. Nipro Business Overview Table 89. Nipro Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Nipro Meloxicam Drugs Product Portfolio Table 91. Nipro Recent Development Table 92. Novitium Pharma Company Information Table 93. Novitium Pharma Business Overview Table 94. Novitium Pharma Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Novitium Pharma Meloxicam Drugs Product Portfolio Table 96. Novitium Pharma Recent Development Table 97. Zydus Company Information Table 98. Zydus Business Overview Table 99. Zydus Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Zydus Meloxicam Drugs Product Portfolio Table 101. Zydus Recent Development Table 102. Jiangsu Jibeier Pharmaceutical Company Information Table 103. Jiangsu Jibeier Pharmaceutical Business Overview Table 104. Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Product Portfolio Table 106. Jiangsu Jibeier Pharmaceutical Recent Development Table 107. Kelun Pharmaceutical Company Information Table 108. Kelun Pharmaceutical Business Overview Table 109. Kelun Pharmaceutical Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Kelun Pharmaceutical Meloxicam Drugs Product Portfolio Table 111. Kelun Pharmaceutical Recent Development Table 112. Luye Pharma Company Information Table 113. Luye Pharma Business Overview Table 114. Luye Pharma Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Luye Pharma Meloxicam Drugs Product Portfolio Table 116. Luye Pharma Recent Development Table 117. Qilu Pharmaceutical Company Information Table 118. Qilu Pharmaceutical Business Overview Table 119. Qilu Pharmaceutical Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Qilu Pharmaceutical Meloxicam Drugs Product Portfolio Table 121. Qilu Pharmaceutical Recent Development Table 122. Simcere Pharmaceutical Company Information Table 123. Simcere Pharmaceutical Business Overview Table 124. Simcere Pharmaceutical Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Simcere Pharmaceutical Meloxicam Drugs Product Portfolio Table 126. Simcere Pharmaceutical Recent Development Table 127. Yangtze River Pharmaceutical Company Information Table 128. Yangtze River Pharmaceutical Business Overview Table 129. Yangtze River Pharmaceutical Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Yangtze River Pharmaceutical Meloxicam Drugs Product Portfolio Table 131. Yangtze River Pharmaceutical Recent Development Table 132. YaoPharma Company Information Table 133. YaoPharma Business Overview Table 134. YaoPharma Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. YaoPharma Meloxicam Drugs Product Portfolio Table 136. YaoPharma Recent Development Table 137. Zhejiang Xianju Pharmaceutical Company Information Table 138. Zhejiang Xianju Pharmaceutical Business Overview Table 139. Zhejiang Xianju Pharmaceutical Meloxicam Drugs Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Zhejiang Xianju Pharmaceutical Meloxicam Drugs Product Portfolio Table 141. Zhejiang Xianju Pharmaceutical Recent Development Table 142. North America Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. North America Meloxicam Drugs Sales by Country (2021-2026) & (W Units) Table 144. North America Meloxicam Drugs Sales Market Share by Country (2021-2026) Table 145. North America Meloxicam Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 146. North America Meloxicam Drugs Sales Market Share Forecast by Country (2027-2032) Table 147. North America Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Meloxicam Drugs Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Meloxicam Drugs Market Share by Country (2021-2026) Table 150. North America Meloxicam Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Meloxicam Drugs Market Share Forecast by Country (2027-2032) Table 152. Europe Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Europe Meloxicam Drugs Sales by Country (2021-2026) & (W Units) Table 154. Europe Meloxicam Drugs Sales Market Share by Country (2021-2026) Table 155. Europe Meloxicam Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 156. Europe Meloxicam Drugs Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Meloxicam Drugs Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Meloxicam Drugs Market Share by Country (2021-2026) Table 160. Europe Meloxicam Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Meloxicam Drugs Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Meloxicam Drugs Sales by Country (2021-2026) & (W Units) Table 164. Asia-Pacific Meloxicam Drugs Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Meloxicam Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 166. Asia-Pacific Meloxicam Drugs Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Meloxicam Drugs Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Meloxicam Drugs Market Share by Country (2021-2026) Table 170. Asia-Pacific Meloxicam Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Meloxicam Drugs Market Share Forecast by Country (2027-2032) Table 172. Latin America Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 173. Latin America Meloxicam Drugs Sales by Country (2021-2026) & (W Units) Table 174. Latin America Meloxicam Drugs Sales Market Share by Country (2021-2026) Table 175. Latin America Meloxicam Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 176. Latin America Meloxicam Drugs Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Meloxicam Drugs Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Meloxicam Drugs Market Share by Country (2021-2026) Table 180. Latin America Meloxicam Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Meloxicam Drugs Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Meloxicam Drugs Sales by Country (2021-2026) & (W Units) Table 184. Middle East and Africa Meloxicam Drugs Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Meloxicam Drugs Sales Forecast by Country (2027-2032) & (W Units) Table 186. Middle East and Africa Meloxicam Drugs Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Meloxicam Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Meloxicam Drugs Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Meloxicam Drugs Market Share by Country (2021-2026) Table 190. Middle East and Africa Meloxicam Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Meloxicam Drugs Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Meloxicam Drugs Distributors List Table 195. Meloxicam Drugs Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Meloxicam Drugs Image Figure 2. Global Meloxicam Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meloxicam Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Meloxicam Drugs Sales (2021-2032) & (W Units) Figure 5. Oral Preparations Image Figure 6. Global Oral Preparations Sales YoY Growth (2021-2032) & (W Units) Figure 7. Topical Preparations Image Figure 8. Global Topical Preparations Sales YoY Growth (2021-2032) & (W Units) Figure 9. Injections Image Figure 10. Global Injections Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Meloxicam Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Meloxicam Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Meloxicam Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Meloxicam Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Meloxicam Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Meloxicam Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Meloxicam Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Meloxicam Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Meloxicam Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Meloxicam Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Meloxicam Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Meloxicam Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Meloxicam Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacy Image Figure 26. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (W Units) Figure 27. Online Pharmacy Image Figure 28. Global Online Pharmacy Sales YoY Growth (2021-2032) & (W Units) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Meloxicam Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Meloxicam Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Meloxicam Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Meloxicam Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Meloxicam Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Meloxicam Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Meloxicam Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Meloxicam Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Meloxicam Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Meloxicam Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Meloxicam Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Meloxicam Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Meloxicam Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Meloxicam Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Meloxicam Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Meloxicam Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Meloxicam Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Meloxicam Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Meloxicam Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Meloxicam Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Meloxicam Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Meloxicam Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Meloxicam Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Meloxicam Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Meloxicam Drugs Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Meloxicam Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Meloxicam Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Meloxicam Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Meloxicam Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Meloxicam Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Preparations
  • Topical Preparations
  • Injections
Applications
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Companies covered
  • Boehringer Ingelheim
  • Iroko Pharmaceuticals
  • Lupin
  • Nipro
  • Novitium Pharma
  • Zydus
  • Jiangsu Jibeier Pharmaceutical
  • Kelun Pharmaceutical
  • Luye Pharma
  • Qilu Pharmaceutical
  • Simcere Pharmaceutical
  • Yangtze River Pharmaceutical
  • YaoPharma
  • Zhejiang Xianju Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Meloxicam Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Meloxicam Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Meloxicam Drugs Market by Type
  6. 1.3.1 Oral Preparations
  7. 1.3.2 Topical Preparations
  8. 1.3.3 Injections
  9. 1.4 Global Meloxicam Drugs Market Size by Type
  10. 1.4.1 Global Meloxicam Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Meloxicam Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Meloxicam Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Meloxicam Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Meloxicam Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Meloxicam Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Meloxicam Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Meloxicam Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Meloxicam Drugs Industry Trends
  2. 2.2 Meloxicam Drugs Industry Drivers
  3. 2.3 Meloxicam Drugs Industry Opportunities and Challenges
  4. 2.4 Meloxicam Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Meloxicam Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Meloxicam Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Meloxicam Drugs Price (2021-2026)
  4. 3.4 Global Meloxicam Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Meloxicam Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Meloxicam Drugs Company, Product Type & Application
  7. 3.7 Global Meloxicam Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Meloxicam Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Meloxicam Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Meloxicam Drugs Tier 1, Tier 2, and Tier 3
4 Meloxicam Drugs Regional Status and Outlook
  1. 4.1 Global Meloxicam Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Meloxicam Drugs Historic Market Size by Region
  3. 4.2.1 Global Meloxicam Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Meloxicam Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Meloxicam Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Meloxicam Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Meloxicam Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Meloxicam Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Meloxicam Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Meloxicam Drugs by Application
  1. 5.1 Meloxicam Drugs Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Retail Pharmacy
  5. 5.2 Global Meloxicam Drugs Market Size by Application
  6. 5.2.1 Global Meloxicam Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Meloxicam Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Meloxicam Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Meloxicam Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Meloxicam Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Meloxicam Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Meloxicam Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Meloxicam Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Meloxicam Drugs Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Iroko Pharmaceuticals
  8. 6.2.1 Iroko Pharmaceuticals Company Information
  9. 6.2.2 Iroko Pharmaceuticals Business Overview
  10. 6.2.3 Iroko Pharmaceuticals Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Iroko Pharmaceuticals Meloxicam Drugs Product Portfolio
  12. 6.2.5 Iroko Pharmaceuticals Recent Developments
  13. 6.3 Lupin
  14. 6.3.1 Lupin Company Information
  15. 6.3.2 Lupin Business Overview
  16. 6.3.3 Lupin Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lupin Meloxicam Drugs Product Portfolio
  18. 6.3.5 Lupin Recent Developments
  19. 6.4 Nipro
  20. 6.4.1 Nipro Company Information
  21. 6.4.2 Nipro Business Overview
  22. 6.4.3 Nipro Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nipro Meloxicam Drugs Product Portfolio
  24. 6.4.5 Nipro Recent Developments
  25. 6.5 Novitium Pharma
  26. 6.5.1 Novitium Pharma Company Information
  27. 6.5.2 Novitium Pharma Business Overview
  28. 6.5.3 Novitium Pharma Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novitium Pharma Meloxicam Drugs Product Portfolio
  30. 6.5.5 Novitium Pharma Recent Developments
  31. 6.6 Zydus
  32. 6.6.1 Zydus Company Information
  33. 6.6.2 Zydus Business Overview
  34. 6.6.3 Zydus Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zydus Meloxicam Drugs Product Portfolio
  36. 6.6.5 Zydus Recent Developments
  37. 6.7 Jiangsu Jibeier Pharmaceutical
  38. 6.7.1 Jiangsu Jibeier Pharmaceutical Company Information
  39. 6.7.2 Jiangsu Jibeier Pharmaceutical Business Overview
  40. 6.7.3 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Jiangsu Jibeier Pharmaceutical Meloxicam Drugs Product Portfolio
  42. 6.7.5 Jiangsu Jibeier Pharmaceutical Recent Developments
  43. 6.8 Kelun Pharmaceutical
  44. 6.8.1 Kelun Pharmaceutical Company Information
  45. 6.8.2 Kelun Pharmaceutical Business Overview
  46. 6.8.3 Kelun Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kelun Pharmaceutical Meloxicam Drugs Product Portfolio
  48. 6.8.5 Kelun Pharmaceutical Recent Developments
  49. 6.9 Luye Pharma
  50. 6.9.1 Luye Pharma Company Information
  51. 6.9.2 Luye Pharma Business Overview
  52. 6.9.3 Luye Pharma Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Luye Pharma Meloxicam Drugs Product Portfolio
  54. 6.9.5 Luye Pharma Recent Developments
  55. 6.10 Qilu Pharmaceutical
  56. 6.10.1 Qilu Pharmaceutical Company Information
  57. 6.10.2 Qilu Pharmaceutical Business Overview
  58. 6.10.3 Qilu Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Qilu Pharmaceutical Meloxicam Drugs Product Portfolio
  60. 6.10.5 Qilu Pharmaceutical Recent Developments
  61. 6.11 Simcere Pharmaceutical
  62. 6.11.1 Simcere Pharmaceutical Company Information
  63. 6.11.2 Simcere Pharmaceutical Business Overview
  64. 6.11.3 Simcere Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Simcere Pharmaceutical Meloxicam Drugs Product Portfolio
  66. 6.11.5 Simcere Pharmaceutical Recent Developments
  67. 6.12 Yangtze River Pharmaceutical
  68. 6.12.1 Yangtze River Pharmaceutical Company Information
  69. 6.12.2 Yangtze River Pharmaceutical Business Overview
  70. 6.12.3 Yangtze River Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Yangtze River Pharmaceutical Meloxicam Drugs Product Portfolio
  72. 6.12.5 Yangtze River Pharmaceutical Recent Developments
  73. 6.13 YaoPharma
  74. 6.13.1 YaoPharma Company Information
  75. 6.13.2 YaoPharma Business Overview
  76. 6.13.3 YaoPharma Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 YaoPharma Meloxicam Drugs Product Portfolio
  78. 6.13.5 YaoPharma Recent Developments
  79. 6.14 Zhejiang Xianju Pharmaceutical
  80. 6.14.1 Zhejiang Xianju Pharmaceutical Company Information
  81. 6.14.2 Zhejiang Xianju Pharmaceutical Business Overview
  82. 6.14.3 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Zhejiang Xianju Pharmaceutical Meloxicam Drugs Product Portfolio
  84. 6.14.5 Zhejiang Xianju Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Meloxicam Drugs Sales by Country
  2. 7.1.1 North America Meloxicam Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Meloxicam Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Meloxicam Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Meloxicam Drugs Market Size by Country
  6. 7.2.1 North America Meloxicam Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Meloxicam Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Meloxicam Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Meloxicam Drugs Sales by Country
  2. 8.1.1 Europe Meloxicam Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Meloxicam Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Meloxicam Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Meloxicam Drugs Market Size by Country
  6. 8.2.1 Europe Meloxicam Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Meloxicam Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Meloxicam Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Meloxicam Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Meloxicam Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Meloxicam Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Meloxicam Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Meloxicam Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Meloxicam Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Meloxicam Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Meloxicam Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Meloxicam Drugs Sales by Country
  2. 10.1.1 South America Meloxicam Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Meloxicam Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Meloxicam Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Meloxicam Drugs Market Size by Country
  6. 10.2.1 South America Meloxicam Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Meloxicam Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Meloxicam Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Meloxicam Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Meloxicam Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Meloxicam Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Meloxicam Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Meloxicam Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Meloxicam Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Meloxicam Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Meloxicam Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Meloxicam Drugs Value Chain Analysis
  2. 12.1.1 Meloxicam Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Meloxicam Drugs Production Mode & Process
  7. 12.2 Meloxicam Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Meloxicam Drugs Distributors
  10. 12.2.3 Meloxicam Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst